Baillie Gifford & Co’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Baillie Gifford & Co's ALAB Position: Q2 2026 in Review
Baillie Gifford & Co reduced its Astera Labs (ALAB) stake by 11% in Q2 2026, selling an estimated $7.08M and leaving 218,430 shares worth $106M. The position accounts for 0.1% of the portfolio, ranked #131.
Baillie Gifford & Co first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Baillie Gifford & Co held 218,430 shares of Astera Labs worth $106M as of Q2 2026.
- Baillie Gifford & Co sold 26,698 Astera Labs shares in Q2 2026, an estimated $7.08M.
- Astera Labs made up 0.1% of Baillie Gifford & Co's portfolio in Q2 2026, its #131 holding.
- Baillie Gifford & Co first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
- 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.